Publications

Selected Publications

  1. McKinnon T, Venier R, Yohe M, Sindiri S, Gryder B, Shern J, Kabaroff L, Dickson B, Schleicher K, Chouinard-Pelletier G, Menezes S, Gupta A, Zhang X, Guha R, Ferrer M, Thomas C, Wei Y, Davani D, Guidos CJ, Khan J, Gladdy RA. Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma. Oncogene. 2018 Feb 28; 37(20):2630-2644.
  2. Gervais MK, Burtenshaw SM, Maxwell J, Dickson BC, Catton CN, Blackstein M, McCready D, Escallon J, Gladdy RA. Clinical outcomes in breast angiosarcoma patients: A rare tumor with unique challenges. J Surg Oncology. 2017 Dec; 116(8):1056-1061.
  3. Burtenshaw SM, Cannell AJ, McAlister ED, Siddique S, Kandel R, Blackstein ME, Swallow CJ, Gladdy RA. Toward observation as first-line management in abdominal desmoid tumors. Ann Surg Oncol. 2016 Jul 1; 23(7):2212-9. With Editorial by van Broekhoven DL, Grunhagen DJ, Verhoef C, Ann Surg Oncol.
  4. Babichev Y, Kabaroff L, Datti A, Uehling D, Isaac M, Al-Awar R, Prakesch M, Sun RX, Boutros PC, Venier R, Dickson BC, Gladdy RA. PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma. J Transl Med. 2016 Mar 8; 14:67.
  5. McKinnon T, Venier R, Dickson BC, Kabaroff L, Alkema M, Chen L, Shern JF, Yohe ME, Khan J, Gladdy RA. Kras activation in p53-deficient myoblasts results in high-grade sarcoma formation with impaired myogenic differentiation. Oncotarget. 2015 Jun 10; 6(16):14220-14232.
  6. Kabaroff L, Gupta A, Menezes S, Babichev Y, Kandel RC, Swallow CJ, Dickson BC, Gladdy RA. Development of genetically flexible mouse models of sarcoma using RCAS-TVA mediated gene delivery. PLoS One. 2014 Apr; 9(4):e94817.
  7. Gladdy RA, Qin LX, Moraco N, Agaram NP, Brennan MF, Singer S. Predictors of survival and recurrence in primary leiomyosarcoma. Ann Surg Oncol. 2013 Jun 1; 20(6):1851-7.
  8. Gladdy RA, Qin LX, Moraco N, Edgar MA, Antonescu CR, Alektiar KM, Brennan MF, Singer S. Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas? J Clin Oncol. 2010 Apr 20; 28(12):2064-9.

   Our Team Contact/Apply